DexCom (DXCM) Tops Q1 EPS by 5c, provides guidance
Get Alerts DXCM Hot Sheet
Price: $91.67 +1.61%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.32, $0.05 better than the analyst estimate of $0.27. Revenue for the quarter came in at $921 million versus the consensus estimate of $909.93 million.
GUIDANCE:
DexCom sees FY2024 revenue of $4.2-4.35 billion, versus the consensus of $4.327 billion.
Non-GAAP Gross Profit Margin of approximately 63 - 64%
Non-GAAP Operating Margin of approximately 20%
Adjusted EBITDA Margin of approximately 29%
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share